Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

Major U.S. equities indexes advanced Thursday, supported by better-than-expected quarterly results from companies like PepsiCo and a positive travel outlook from United Airlines. However, market gains were tempered by significant declines in Elevance Health, which cut its profit outlook due to rising costs, and Abbott Laboratories, impacted by plunging COVID-19 testing sales. Other notable movements included CSX and Norfolk Southern climbing on acquisition speculation, while Union Pacific shares dropped. Broadly, oil and the dollar strengthened, while gold and Treasury yields saw slight declines.

Analysis

U.S. equity markets showed broad gains at midday, though the advance in major indexes masks significant divergence at the stock and sector level driven by quarterly earnings reports and forward guidance. Positive momentum was fueled by firms like PepsiCo (PEP), which beat profit and sales estimates on the back of strong international demand, and United Airlines (UAL), which posted higher-than-anticipated earnings and offered a positive outlook for travel. The railroad sector also saw a catalyst, with CSX (CSX) and Norfolk Southern (NSC) shares climbing on speculation that they are acquisition targets for rival Union Pacific (UNP), whose own stock declined on the news. Conversely, the healthcare sector faced substantial headwinds. Elevance Health (ELV) was the S&P 500's worst performer after a profit miss and a slashed outlook attributed to rising costs for Affordable Care Act and Medicaid coverage, creating a drag on other providers. Similarly, Abbott Laboratories (ABT) shares fell after the company narrowed its full-year outlook, citing a 46% year-over-year plunge in COVID-19 testing sales. Further weakness was seen in commodity suppliers like Archer Daniels Midland (ADM) and Ingredion (INGR), which slipped on reports that a key customer may switch away from high-fructose corn syrup.

Key Decisions for Investors

• Given the significant performance dispersion, investors should prioritize stock-specific fundamentals over broad index exposure, focusing on companies demonstrating resilient demand and pricing power.
• Exercise caution with the health insurance sector, as Elevance Health's guidance cut on rising medical costs signals potential margin pressure across the industry.
• Monitor the railroad sector for event-driven trading opportunities stemming from potential M&A activity involving Union Pacific, CSX, and Norfolk Southern.
• Scrutinize companies that heavily benefited from the pandemic, as Abbott Labs' sharp decline in COVID-19 testing revenue highlights the ongoing risk of post-pandemic normalization.